Merck KGaA
MKKGY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $60 | $61 | $78 | $100 |
| - Cash | $2 | $2 | $1 | $2 |
| + Debt | $10 | $10 | $10 | $11 |
| Enterprise Value | $68 | $69 | $87 | $109 |
| Revenue | $21 | $21 | $22 | $20 |
| % Growth | 0.8% | -5.6% | 12.9% | – |
| Gross Profit | $12 | $12 | $14 | $12 |
| % Margin | 59% | 59% | 61.6% | 62.7% |
| EBITDA | $6 | $6 | $6 | $6 |
| % Margin | 28.2% | 27.1% | 28.2% | 29.9% |
| Net Income | $3 | $3 | $3 | $3 |
| % Margin | 13.1% | 13.5% | 15% | 15.5% |
| EPS Diluted | 1.28 | 1.3 | 1.53 | 1.41 |
| % Growth | -1.5% | -15% | 8.5% | – |
| Operating Cash Flow | $5 | $4 | $4 | $5 |
| Capital Expenditures | -$2 | -$2 | -$2 | -$1 |
| Free Cash Flow | $2 | $2 | $2 | $3 |